Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Petition Requests Skin Treatment GRASE For Ophthalmic Monograph Ingredient

This article was originally published in The Tan Sheet

Executive Summary

A beauty professional says an eye redness reliever containing tetrahydrozoline hydrochloride – included in FDA’s OTC monograph for ophthalmic drug products – safely and effectively controls redness from acne and other skin ailments. She requests adding the ingredient to the skin protectant drug monograph.


Related Content

FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts